Northfield Laboratories Inc. Announces Second Quarter 2009 Financial Results Webcast
05 Janeiro 2009 - 7:43PM
Business Wire
Northfield Laboratories Inc. (Nasdaq: NFLD) will host its second
quarter 2009 earnings conference call with the financial community
on Monday, January 12, 2009 at 11:00 a.m. Eastern Time (10 a.m.
Central Time). This call is being webcast by Thomson Reuters and
can be accessed at Northfield's Web site at
http://www.northfieldlabs.com. A replay will be available in the
same location for two weeks following the call. The webcast is also
being distributed through the Thomson StreetEvents Network to both
institutional and individual investors. Individual investors can
listen to the call at http://www.fulldisclosure.com, Thomson
Reuters individual investor portal, powered by StreetEvents.
Institutional investors can access the call via Thomson's
password-protected event management site, StreetEvents
(http://www.streetevents.com). Investors may also dial 866.783.2139
and enter the passcode 97752406. A replay of the call will be
available for two weeks by dialing 888.286.8010 and entering the
passcode 34016526. About Northfield Laboratories Northfield
Laboratories is a leader in developing a hemoglobin-based
oxygen-carrying red blood cell substitute. The initial indication
we are seeking for our investigational product PolyHeme is the
treatment of life-threatening red blood cell loss when an
oxygen-carrying fluid is required and red blood cells are not
available. PolyHeme is a solution of chemically modified human
hemoglobin that requires no cross-matching and is therefore
compatible with all blood types. It has an extended shelf life in
excess of 12 months. For further information, visit
http://www.northfieldlabs.com.
Northfield labs (NASDAQ:NFLD)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Northfield labs (NASDAQ:NFLD)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
Notícias em tempo-real sobre Northfield Laboratories Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Northfield Laboratories Inc.